2025-03-03 |
2025-02-28 |
B
Purchase
|
Glover Stephen C.
Non-Executive Director
|
15,061
+23.6%
1.66
USD 25,001
|
15,061
+23.6%
|
1.66
|
USD 25,001
|
|
2025-03-03 |
2025-02-28 |
B
Purchase
|
Freitag Gregory Gene
Non-Executive Director
|
15,060
+32.6%
1.66
USD 25,000
|
15,060
+32.6%
|
1.66
|
USD 25,000
|
|
2021-12-14 |
2021-12-13 |
B
Purchase
|
HILL MATTHEW C
Chief Financial Officer
Officer
|
100
+2.5%
9.00
USD 900
|
100
+2.5%
|
9.00
|
USD 900
|
|
2021-12-14 |
2021-12-13 |
B
Purchase
|
HILL MATTHEW C
Chief Financial Officer
Officer
|
100
+2.6%
9.00
USD 900
|
100
+2.6%
|
9.00
|
USD 900
|
|
2021-12-14 |
2021-12-13 |
B
Purchase
|
HILL MATTHEW C
Chief Financial Officer
Officer
|
400
+11.5%
8.90
USD 3,560
|
400
+11.5%
|
8.90
|
USD 3,560
|
|
2021-12-14 |
2021-12-13 |
B
Purchase
|
HILL MATTHEW C
Chief Financial Officer
Officer
|
2,500
+256.4%
9.00
USD 22,500
|
2,500
+256.4%
|
9.00
|
USD 22,500
|
|
2021-06-21 |
2021-06-16 |
B
Purchase
|
Bloomquist DeLyle W
See Remarks
|
10,000
+5.4%
9.88
USD 98,778
|
10,000
+5.4%
|
9.88
|
USD 98,778
|
|
2021-06-17 |
2021-06-15 |
B
Purchase
|
Ali-Jackson Kamil
Non-Executive Director
|
11,764
+inf%
8.50
USD 99,994
|
11,764
+inf%
|
8.50
|
USD 99,994
|
|
2021-06-17 |
2021-06-15 |
B
Purchase
|
Glover Steve C
Non-Executive Director
|
5,882
+10.2%
8.50
USD 49,997
|
5,882
+10.2%
|
8.50
|
USD 49,997
|
|
2021-06-17 |
2021-06-15 |
B
Purchase
|
Freitag Gregory Gene
Non-Executive Director
|
5,882
+14.6%
8.50
USD 49,997
|
5,882
+14.6%
|
8.50
|
USD 49,997
|
|
2021-06-17 |
2021-06-15 |
B
Purchase
|
VAN VOORHEES SETH
Chief Financial Officer
Officer
|
17,647
+inf%
8.50
USD 150,000
|
17,647
+inf%
|
8.50
|
USD 150,000
|
|
2018-03-22 |
2018-03-22 |
PS
Planned sale
|
Macdonald R. Loch
Chief Scientific Officer
Executive Director
|
2,500
-0.4%
16.41
USD 41,025
|
2,500
-0.4%
|
16.41
|
USD 41,025
|
|
2018-03-21 |
2018-03-21 |
PS
Planned sale
|
Macdonald R. Loch
Chief Scientific Officer
Executive Director
|
2,500
-0.4%
16.52
USD 41,300
|
2,500
-0.4%
|
16.52
|
USD 41,300
|
|
2018-03-21 |
2018-03-20 |
PS
Planned sale
|
Macdonald R. Loch
Chief Scientific Officer
Executive Director
|
5,000
-0.9%
16.47
USD 82,350
|
5,000
-0.9%
|
16.47
|
USD 82,350
|
|
2018-03-21 |
2018-03-19 |
PS
Planned sale
|
Macdonald R. Loch
Chief Scientific Officer
Executive Director
|
2,500
-0.4%
16.66
USD 41,650
|
2,500
-0.4%
|
16.66
|
USD 41,650
|
|
2018-03-05 |
2018-03-02 |
PS
Planned sale
|
Leuthner Brian A
President and CEO
Executive Director
|
2,500
-3.4%
15.08
USD 37,700
|
2,500
-3.4%
|
15.08
|
USD 37,700
|
|
2018-03-05 |
2018-03-01 |
PS
Planned sale
|
Leuthner Brian A
President and CEO
Executive Director
|
2,500
-3.3%
14.81
USD 37,025
|
2,500
-3.3%
|
14.81
|
USD 37,025
|
|
2018-02-23 |
2018-02-23 |
PS
Planned sale
|
Leuthner Brian A
President and CEO
Executive Director
|
2,500
-3.2%
15.37
USD 38,425
|
2,500
-3.2%
|
15.37
|
USD 38,425
|
|
2018-02-23 |
2018-02-22 |
PS
Planned sale
|
Leuthner Brian A
President and CEO
Executive Director
|
2,500
-3.1%
15.47
USD 38,675
|
2,500
-3.1%
|
15.47
|
USD 38,675
|
|
2018-02-22 |
2018-02-22 |
PS
Planned sale
|
Macdonald R. Loch
Chief Scientific Officer
Executive Director
|
2,500
-0.4%
14.49
USD 36,225
|
2,500
-0.4%
|
14.49
|
USD 36,225
|
|